Standard BioTools Inc (NAS:LAB)
$ 1.86 0.02 (1.09%) Market Cap: 688.98 Mil Enterprise Value: 318.60 Mil PE Ratio: 0 PB Ratio: 1.23 GF Score: 75/100

Fluidigm Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 28, 2021 / 06:00PM GMT
Release Date Price: $6.42 (-3.31%)
Charles Duncan
Cantor Fitzgerald - Managing Director

Hello. Welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Duncan, and I'm a managing director and senior biotechnology analyst with firm's Equity Research department. This is -- this is day number two of our annual conference. And I have to say, this has been really a pretty wild year, this last year.

But it is a pleasure to introduce the next presenting Company that is Fluidigm. And with me today, I have the Company CEO, Christopher Linthwaite. Christopher, how are you doing today? Good to see you.

Christopher Linthwaite
Fluidigm - CEO

It's nice to see you, too, Charles. I really appreciate the invitation on behalf of the Fluidigm organization to the Cantor conference.

Charles Duncan
Cantor Fitzgerald - Managing Director

Well, thank you very much for joining us today. Unfortunately, at this point, I do not cover Fluidigm. So what I thought we would do is have you run through a PowerPoint presentation. Tell us a little bit

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot